Therapeutic Advances and Key Case Studies in RCC

EP. 1: Introduction and Frontline Treatment of RCC

June 25th 2014

EP. 2: High-Risk Renal Cell Carcinoma Treatment

June 25th 2014

EP. 3: Prognostic Factors and Treatment Selection in RCC

June 25th 2014

EP. 4: Risk Stratification in Renal Cell Carcinoma

June 25th 2014

EP. 5: Role of Cytoreductive Nephrectomy in mRCC

June 25th 2014

EP. 6: Alternative Dosing Schedules for Targeted Agents in RCC

June 25th 2014

EP. 7: Treatment-Related Adverse Events in RCC

June 25th 2014

EP. 8: Treatment Considerations in Renal Cell Carcinoma

June 25th 2014

EP. 9: First-line Therapy for Renal Cell Carcinoma

June 25th 2014

EP. 10: Second-Line Treatment Selection in RCC

June 25th 2014

EP. 11: Immunotherapy in Renal Cell Carcinoma

June 25th 2014

EP. 12: Nivolumab in Renal Cell Carcinoma

June 25th 2014

EP. 13: PD-1 Inhibition in Renal Cell Carcinoma

June 25th 2014

EP. 14: Role of TKIs in Oligometastatic RCC

June 25th 2014

EP. 15: Palliative Care for Patients With RCC

June 25th 2014

EP. 16: Changing Treatment Landscape for RCC

June 25th 2014